Akiko Uchida, Yasushi Isobe, Junko Asano, Yu Uemura, Masahiro Hoshikawa, Masayuki Takagi, and Ikuo Miura. 2019. “Targeting BCL2 With Venetoclax Is a Promising Therapeutic Strategy for ‘double-proteinexpression’ Lymphoma With MYC and BCL2 Rearrangements”. Haematologica 104 (7). Pavia, Italy, 1417-21. https://doi.org/10.3324/haematol.2018.204958.